PHD N-Deca 250 10 ml – Nandrolone Decanoate Injectable Support
PHD N-Deca 250 contains Nandrolone Decanoate 250mg/ml, a long-acting injectable compound commonly chosen in structured muscle-building routines focused on steady development, strength progression, and recovery support. Its slow-release ester allows consistent activity over time, making it suitable for longer performance-focused programs.
This formulation is often selected by individuals aiming for gradual progress while maintaining stable support throughout a cycle.
Buy Deca N
How PHD N-Deca 250 Works
Nandrolone Decanoate supports protein synthesis, nitrogen retention, and red blood cell production, helping maintain muscle quality and improve recovery during demanding training phases. Its long ester profile provides extended release, reducing administration frequency while maintaining stable support.
Key Benefits
• Supports lean muscle development
• Promotes strength and endurance
• Helps improve recovery between sessions
• Long-acting formula for stable release
• Suitable for mass and strength-focused routines
Recommended Usage
PHD N-Deca 250 is generally included in structured weekly routines depending on goals and individual planning. Its long-acting ester allows wider spacing between administrations compared to shorter compounds.
Product Features
• Strength: 250mg/ml
• Compound: Nandrolone Decanoate
• Ester Type: Decanoate (long-acting)
• Presentation: 10 ml vial
• Best For: Mass support, strength, and recovery
Product details
Raw Material: Nandrolone Decanoate
• Manufacturer: Aslan Pharma
• Package: 10 ml vial (300 mg/ml)
• Active Half-Life: Approximately 6–7 days
• Classification: Injectable anabolic compound
• Typical Usage Range: Men 300–600 mg per week
• Acne Potential: Generally low
• Water Retention: Possible depending on individual response
• HBR: May vary by user
• Liver Impact: Not commonly associated with liver strain
• Aromatization: Minimal direct conversion profile
• Active Substance: Nandrolone Decanoate





Reviews
There are no reviews yet.